Objectives: I-123 is considered an ideal isotope for diagnostic studies. A significant advantage of I-123 over I-131 is that, the radiation dose delivered is about 100-fold less. Consequently, potential ''stunning'' because of the dosimetry procedure prior to treatment would be less concerning.
because of the dosimetry procedure prior to treatment would be less concerning.
However, its relatively short half-life makes it impractical for a prolonged bio kinetic study. The aim of the current study was to assess the relationship between actual I-131 retention and the success rate 
INTRODUCTION:
The role of radioactive as an adjuvant therapy following surgery in the management of patients with differentiated thyroid cancer (DTC) is well
. Radioactive Iodine ablation has five proposed objectives. 
.
It has been reported that the success rate of I-131 ablation is severely reduced after a dosimetry study with diagnostic activity of 40 MBq I-131
. Diagnostic activity of I-123 has been used as an alternative to I-131, and no known stunning has been reported (24). However, its relatively short half-life makes it impractical for a prolonged bio kinetic study Calculation of retained activity: The retained activity at 48 h was calculated based on the external exposure rate measurement using the following formula:
Where A48 is the retained activity at 48 h; A0 is the administered activity; EWB48, EWB0 are the whole body external exposure rates at one meter from the patient 48 h and immediately after ingestion of the 131I activity respectively.
Calculation of the whole body effective half-life of I-131The whole body effective half-life was then calculated using the following formula: (2 hours (p = 002) respectively for patients who need re-ablation (Figures 1 and 2 ). The effect of gender on the whole body retained I-131 activity at 48 hours is shown in Table 3 and the effect of gender on the I-131 effective half-life is shown in Table 4 .
There was no significant difference in either the whole body retained I-131 activity at 48 hours or the I-131 effective half-life between male and female patients with DTC. In 87 patients of 16.5 ± 8.7% with mean retention of I-131 at day 2 in females was almost identical to that in males (16.6%, and 16.4% respectively).
Another study, Van Nostrand et al.
showed the utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of I-131 of 14.4 ± 8.9%, which is also in line with our results.
In current study, the effective half-life was 
